ESC recommends uninterrupted vitamin K antagonists during ablation and device implantation
Milan, Italy - 23 June 2015: The European Society of Cardiology (ESC) has recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device implantation in a position paper presented today1 at EHRA EUROPACE - CARDIOSTIM 2015 and published in EP Europace.2 'Antithrombotic management in patients undergoing electrophysiology procedures' was produced by the European Heart Rhythm Association (EHRA), a registered branch of the ESC, and is endorsed by the ESC Working Group on Thrombosis, the Heart Rhythm Society (HRS) in the US and the Asia Pacific ...
Read the release